EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
94 hedge funds and large institutions have $207M invested in Eiger BioPharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 34 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
+3
Holders Change %
+3.3%
% of All Funds
1.66%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.04%
New
10
Increased
21
Reduced
34
Closed
7
Calls
$3.56M
Puts
$1.25M
Net Calls
+$2.32M
Net Calls Change
+$436K
Top Buyers
1 |
1
Ameriprise
Minneapolis,
Minnesota
|
$39.4M |
2 |
2
BlackRock
New York
|
$22.2M |
3 |
3
Renaissance Technologies
New York
|
$946K |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$4.96M |
5 |
5
Russell Investments Group
London,
United Kingdom
|
$1.36M |